dc.creatorLuco Illanes, Matías
dc.creatorSalas, Gisela
dc.creatorZavala Busquets, Alejandro Luis
dc.creatorOtano, Jesica
dc.creatorToso Milos, Alberto
dc.creatorReusmann, Aixa
dc.creatorCannizzaro, Claudia
dc.creatorSantelices Ruiz, Felipe
dc.creatorFarina, Diana
dc.creatorLally, Pam
dc.creatorKattan Said, Alberto
dc.date.accessioned2023-12-04T19:45:19Z
dc.date.accessioned2024-05-02T18:57:55Z
dc.date.available2023-12-04T19:45:19Z
dc.date.available2024-05-02T18:57:55Z
dc.date.created2023-12-04T19:45:19Z
dc.date.issued2023
dc.identifier10.1016/j.jpedsurg.2023.01.058
dc.identifier1531-5037
dc.identifier0022-3468
dc.identifierhttps://doi.org/10.1016/j.jpedsurg.2023.01.058
dc.identifierhttps://repositorio.uc.cl/handle/11534/75467
dc.identifierWOS:001034263600001
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/9271644
dc.description.abstractIntroduction: Mortality related to CDH is high, but with great variability among centers. There are few studies on patients with this condition born in South America which show poor outcomes. The goal of this study is to present the outcome of CDH in several high-volume quaternary centers in South America, ascertain the factors associated with lower mortality in our population, and compare our outcomes to those of the CDH Study Group (CDHSG).Methods: The data from two South American centers were retrospectively analyzed and compared with contemporary data from other CDHSG participating centers. Patient demographic and clinical characteristics were also evaluated and compared.Results: Between 2013 and 2018, the two South American centers saw 335 patients with CDH with an overall survival rate of 73.1%. Survival for the high, intermediate, and low-risk groups as determined by the Brindle score was 50%, 70%, and 87%, respectively. In our cohort the strongest predictors of mortality were ECMO use and early PaCO2. There were no significant differences in mortality between the two South American centers and the other CDHSG centers when adjusted by risk score, however, the South American centers had higher use of ECMO in the intermediate-risk group.Discussion: Quaternary South American centers had similar outcomes to CDHSG centers worldwide. The availability and coordination of centralized dedicated care allow more efficient use of scarce technical and professional resources in patients with CDH. Level of evidence: III.& COPY; 2023 Elsevier Inc. All rights reserved.
dc.languageen
dc.publisherW B SAUNDERS CO-ELSEVIER INC
dc.rightsacceso restringido
dc.subjectCongenital diaphragmatic hernia
dc.subjectECMO
dc.subjectECLS
dc.subjectCDH
dc.titleRisk-stratified Results among Congenital Diaphragmatic Hernia Patients in Two Large Extracorporeal Membrane Oxygenation Centers in South America
dc.typeartículo


Este ítem pertenece a la siguiente institución